Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Allurion Technologies, Inc.

Release the AUDACITY FDA pivotal trial results

Delivered after the deadline (8 days after the deadline)

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
8 Jan 2024
Due
31 Dec 2024
Delivered
8 Jan 2025
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“including the AUDACITY FDA pivotal trial read-out expected by end of year”

What we found

Evidence strength A What the grades mean

The company announced the topline results of the AUDACITY pivotal trial on January 8, 2025, which occurred after the end-of-year 2024 deadline.

  • A
    Allurion Technologies, Inc. 10-K filed 2025-03-27 Regulatory filing · published 27 Mar 2025 · retrieved 25 Sep 2026 · kept permanently by the SEC · fingerprint 6232719d2b2e
    “On January 8, 2025, we announced topline results from our AUDACITY pivotal trial evaluating the safety and efficacy of the Allurion Balloon.” ✓ confirmed on the page

Market reaction: the shares moved +4.5% against the S&P 500 over the three sessions around the disclosure (26 Mar 2025 to 31 Mar 2025). What this measures

Checked 25 Sep 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout late
Indicative materiality
High rules
Action
Release
Language
Expected (“expects”, “plans”)

How this entry was checked

  1. Commitment recordedRecorded from the company's filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Allurion Technologies, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2024-ALURW-000010 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.